Literature DB >> 35814505

Surgical Risk Assessment in Patients with Chronic Liver Diseases.

Shekhar S Jadaun1, Sanjiv Saigal1.   

Abstract

Chronic liver diseases (CLD) is one of the leading causes of morbidity and mortality. The overall life span of patients with CLD has increased and so is the number of surgical procedures these patients undergo. Pathophysiological and hemodynamic changes in cirrhosis make these patients more susceptible to hypotension and hypoxia during surgery. They also have a high risk of drug induced liver injury, renal dysfunction and post-operative liver decompensation. Patients with CLD planned for elective or semi-elective surgery should undergo detailed preoperative risk assessment. Patients should be evaluated for the presence of clinically significant portal hypertension and cirrhosis. In the absence of both cirrhosis and clinically significant portal hypertension, patients with CLD can undergo surgery with minimal or low risk. Various risk assessment tools available for patients with advanced CLD are-CTP score, MELD Score, Mayo risk score, VOCAL-Penn score. A Child class C and/or Mayo risk score >15 in general is associated with high risk of post-operative mortality and elective surgery should be deferred in these patients. In patients with Child class, A and MELD 10-15 surgery is permissible with caution (except liver resection and cardiac surgery) while in Child A and MELD <10 surgery is well tolerated. VOCAL-Penn score is a new promising tool and can be the better alternative of CTP, MELD, and Mayo risk score models but more prospective studies with large patients' population are warranted. Certain surgeries like Hepatic resection, intraabdominal, and cardiothoracic have higher risk than abdominal wall hernia repair and orthopedic surgery. Laparoscopic approaches have better outcomes and less risk of liver failure than open surgery. Minimally invasive alternatives like colonic stent placement in case of obstruction can be considered in high-risk cases. Perioperative optimization and management of ascites, HE, bleeding, liver decompensation, and nutrition should be done with multidisciplinary approach. Patients with cirrhosis undergoing high risk elective surgery can develop liver failure in post-operative period and should be evaluated and counseled for liver transplantation if not contraindicated.
© 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ASA, American Society of Anaesthesiologists; CLD, Chronic liver disease; CTP, Child-Turcotte-Pugh; Cirrhosis; HCC, Hepatocellular carcinoma; HVPG, hepatic venous pressure gradient; MELD, Model for end stage liver disease; NASH, Non-alcoholic steatohepatitis; ROTEM, rotational thromboelastometry; Surgery in cirrhosis; Surgical risk assessment; TEG, Thromboelastography; VOCAL-Penn score, Veterans Outcomes and Costs Associated with Liver Disease-Penn score

Year:  2022        PMID: 35814505      PMCID: PMC9257927          DOI: 10.1016/j.jceh.2022.03.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  78 in total

Review 1.  Assessment of risk for non-hepatic surgery in cirrhotic patients.

Authors:  Prashant Bhangui; Alexis Laurent; Roland Amathieu; Daniel Azoulay
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

2.  Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization.

Authors:  Jacob C Townsend; Richard Heard; Eric R Powers; Adrian Reuben
Journal:  Am J Cardiol       Date:  2012-06-22       Impact factor: 2.778

Review 3.  AGA Clinical Practice Update on Surgical Risk Assessment and Perioperative Management in Cirrhosis: Expert Review.

Authors:  Patrick G Northup; Lawrence S Friedman; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-28       Impact factor: 11.382

4.  MELD and MELD XI Scores as Predictors of Mortality After Pericardiectomy for Constrictive Pericarditis.

Authors:  Juan C Diaz Soto; William J Mauermann; Brian D Lahr; Hartzell V Schaff; Sushil A Luis; Mark M Smith
Journal:  Mayo Clin Proc       Date:  2021-03       Impact factor: 7.616

5.  Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study.

Authors:  Evelyne Vinet; Pierre Perreault; Louis Bouchard; Denis Bernard; Ramses Wassef; Carole Richard; Richard Létourneau; Gilles Pomier-Layrargues
Journal:  Can J Gastroenterol       Date:  2006-06       Impact factor: 3.522

6.  The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.

Authors:  Raquel Rios; Bruno Sangro; Ignacio Herrero; Jorge Quiroga; Jesus Prieto
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

7.  Improving operative safety for cirrhotic liver resection.

Authors:  C C Wu; D C Yeh; M C Lin; T J Liu; F K P'Eng
Journal:  Br J Surg       Date:  2001-02       Impact factor: 6.939

8.  Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy.

Authors:  Daniel Zamora-Valdes; Kymberly D Watt; Todd A Kellogg; John J Poterucha; Sara R Di Cecco; Nicki M Francisco-Ziller; Timucin Taner; Charles B Rosen; Julie K Heimbach
Journal:  Hepatology       Date:  2018-05-14       Impact factor: 17.425

9.  Bariatric Surgery in Patients with Cirrhosis and Portal Hypertension.

Authors:  Zubaidah Nor Hanipah; Suriya Punchai; Arthur McCullough; Srinivasan Dasarathy; Stacy A Brethauer; Ali Aminian; Philip R Schauer
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

10.  Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery.

Authors:  A Ziser; D J Plevak; R H Wiesner; J Rakela; K P Offord; D L Brown
Journal:  Anesthesiology       Date:  1999-01       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.